Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
about
How to manage aspergillosis in non-neutropenic intensive care unit patientsTreatment with echinocandins during continuous renal replacement therapyPharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy.The use of antifungal therapy in neonatal intensive care.The Eagle-like effect of echinocandins: what's in a name?Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.Caspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.Impact of special patient populations on the pharmacokinetics of echinocandins.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Anidulafungin dosing during CRRT: do not underestimate adsorption!Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patientsFilter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro.Current role of echinocandins in the management of invasive aspergillosis.Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation.Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins
P2860
Q26999448-D13783FF-2B52-4CAE-9C34-631A071BE289Q27012864-ABC88536-8AAE-4C03-A8F1-CA5C6BBBB2BAQ37036404-FF146843-D450-4CA1-8C4B-1E71E1561B46Q37985070-A58A431A-CAC6-4127-ACF3-09659DA3A6BAQ38153458-ABF5E7E4-FC6D-41DD-9F27-9E8D96D1D1D0Q38375996-7BA764DC-713D-454B-8C15-8081795A60CDQ38382954-7794BE9F-DCF2-43AA-BBB5-DB6060CA4BD1Q38462784-54C34708-807A-4EB1-9DFC-0A28799B97E8Q38681635-0AEB8FDD-F81D-41EA-B9CF-8C3492EDFCBFQ41921220-5A8A8545-30C4-4EB4-80D9-E4511B60BD65Q42326553-0B04EAEF-5789-4417-9C70-50084F21A387Q48192025-5D95CB01-C1E6-4530-8FA6-ED0801610344Q53217028-4A70A94D-0210-4976-AD43-FA31212D3666Q54957028-22FA5E69-F017-4492-9652-6CBE38690B49Q57746174-D4DC3A50-A314-4584-9CA0-C29DE23D58C1
P2860
Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@en
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@nl
type
label
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@en
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@nl
prefLabel
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@en
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@nl
P2093
P356
P1476
Multiple-dose pharmacokinetics ...... us venovenous haemofiltration.
@en
P2093
Brigitte Meyer
Clara Zuba
Florian Thalhammer
Judith M Leitner
Katrin Saria
Michaela Böhmdorfer
Valentin Fuhrmann
Walter Jäger
P304
P356
10.1093/JAC/DKQ545
P407
P577
2011-01-22T00:00:00Z